Curing amyloidosis: will it work in humans?
- 1 November 1999
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 22 (11) , 485-486
- https://doi.org/10.1016/s0166-2236(99)01489-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999
- Receptor-Mediated Transport of Human Amyloid β-Protein 1–40 and 1–42 at the Blood–Brain BarrierNeurobiology of Disease, 1999
- Molecular genetics of Alzheimer's diseaseAnnals of Medicine, 1998
- Immunopharmacology: immunomodulation and immunotherapyPublished by American Medical Association (AMA) ,1997
- Amyloid, the presenilins and Alzheimer's diseaseTrends in Neurosciences, 1997
- Disaggregation of Alzheimer β-amyloid by site-directed mAbProceedings of the National Academy of Sciences, 1997
- Aging and Alzheimer's Disease: Lessons From the Nun StudyThe Gerontologist, 1997
- Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide.Proceedings of the National Academy of Sciences, 1996
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinNature, 1995
- Blood-Brain Barrier Transport of Circulating Alzheimer′s Amyloid βBiochemical and Biophysical Research Communications, 1993